Patents by Inventor Jutta Haunschild

Jutta Haunschild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment of diseases of the eye
    Patent number: 7648959
    Abstract: Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors ?v ?3 and/or ?v ?5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: January 19, 2010
    Assignee: Merck Patent GmbH
    Inventors: Hans-Markus Bender, Jutta Haunschild, Matthias Wiesner, Ulrich Lang, Martin Friedlander
  • Integrin inhibitors for the treatment of eye diseases
    Patent number: 7645736
    Abstract: Methods for the treatment of a disease of the eye of a patient comprising injecting into the vitreous body of the eye a composition comprising a therapeutically effective amount of an ?v?3 and/or ?v?5 inhibitor sufficient to inhibit angiogenesis and inhibit neovascularization in the treated eye. The ?v?3 and/or ?v?5 inhibitor being a compound of formula II: as defined herein or a physiologically acceptable salt thereof.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: January 12, 2010
    Assignee: Merck Patent GmbH
    Inventors: Hans-Markus Bender, Jutta Haunschild, Ulrich Lang, Matthias Wiesner, Martin Friedlander
  • Integrin inhibitors for the treatment of eye diseases
    Publication number: 20060287225
    Abstract: Methods and compositions for prophylaxis and/or treatment of diseases of the eye using antagonists of the integin receptors ?v?3 and/or ?v?5. The compositions can be nanoparticles and are administered to the eye by injection into the vitreous body of the eye.
    Type: Application
    Filed: August 28, 2006
    Publication date: December 21, 2006
    Inventors: Hans-Markus Bender, Jutta Haunschild, Ulrich Lang, Matthias Wiesner, Martin Friedlander
  • Methods and compositions for the treatment of diseases of the eye
    Publication number: 20060223746
    Abstract: Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors ?v?3 and/or ?v?5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.
    Type: Application
    Filed: June 7, 2006
    Publication date: October 5, 2006
    Inventors: Hans-Markus Bender, Jutta Haunschild, Matthias Wiesner, Ulrich Lang, Martin Friedlander
  • Integrin inhibitors for the treatment of eye diseases
    Publication number: 20040198644
    Abstract: Methods and compositions for prophylaxis and/or treatment of diseases of the eye using antagonists of the integin receptors &agr;v&bgr;3 and/or &agr;v62 5. The compositions can be nanoparticles and are administered to the eye by injection into the vitreous body of the eye.
    Type: Application
    Filed: January 30, 2004
    Publication date: October 7, 2004
    Inventors: Hans-Markus Bender, Jutta Haunschild, Ulrich Lang, Matthias Wiesner, Martin Friedlander
  • Methods and compositions for the treatment of diseases of the eye
    Publication number: 20040029788
    Abstract: Methods and compositions for prophylaxis and/or treatment of diseases of the eye of a patient resulting angiogenesis in the eye using antagonists of the integrin receptors &agr;v&bgr;3 and/or &agr;v&bgr;5. The compositions can be nanoparticles and are administered to the eye by injection into the sclera of the eye.
    Type: Application
    Filed: April 30, 2003
    Publication date: February 12, 2004
    Inventors: Hans-Markus Bender, Jutta Haunschild, Matthias Wiesner, Ulrich Lang, Martin Friedlander
  • Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
    Patent number: 6683051
    Abstract: The invention relates to a pharmaceutical preparation [lacuna] cyclo(Arg-Gly-Asp-D-Phe-NMe-Val) and/or one of its physiologically acceptable salts and at least one chemotherapeutic agent and/or one of its physiologically acceptable salts and/or an angiogenesis inhibitor and/or one of its physiologically acceptable salts.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: January 27, 2004
    Assignee: Merck Patent GmbH
    Inventors: Alfred Jonczyk, Astrid Perschl, Simon Goodman, Sigrid Rösener, Jutta Haunschild